Corium Announces Appointment of Ivan Gergel, M.D. to Board of Directors
MENLO PARK, Calif. , Dec. 8, 2014 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the appointment of Ivan Gergel , M.D….

Corium Announces Closing of Expanded Term Loan Facility with CRG
MENLO PARK, Calif., Dec. 4, 2014 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that it has closed an expanded term loan…